AMBRISENTAN Mepha Lactab 10 mg 30 pce
7680672940021
CH-67294
C02KX02
02.07.1.
Reimbursement limitations:
VOLIBRIS
Traitement de l’hypertension artérielle pulmonaire idiopathique (HTAPI) et de l’HTAP associée à des affections de …
1 / 3
google
Details
- Product number
- 6729402
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- Filmtablette: ambrisentanum 10 mg, lactosum monohydricum 150 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.22 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, pro compresso obducto.
Articles (1)
Ambrisentan-Mepha 10 mg, Lactab
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
150.0 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
0.22 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 1093.70
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2021
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67294
- Drug name
- Ambrisentan-Mepha, Lactab
- Galenic form
- TAB
- ATC Code
- C02KX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMBRISENTAN Mepha Lactab 10 mg 30 pce
- Description (DE)
- AMBRISENTAN Mepha Lactab 10 mg 30 Stk
- Market launch
- 27/10/2020
- Narcotic (BTM)
- No